Works matching IS 11732563 AND DT 2015 AND VI 35 AND IP 2
Results: 8
A Pooled Analysis Evaluating the Efficacy and Tolerability of Tapentadol Extended Release for Chronic, Painful Diabetic Peripheral Neuropathy.
- Published in:
- Clinical Drug Investigation, 2015, v. 35, n. 2, p. 95, doi. 10.1007/s40261-014-0249-3
- By:
- Publication type:
- Article
Stroke and Systemic Embolism Prevention in Patients with Atrial Fibrillation in Belgium: Comparative Cost Effectiveness of New Oral Anticoagulants and Warfarin.
- Published in:
- Clinical Drug Investigation, 2015, v. 35, n. 2, p. 109, doi. 10.1007/s40261-014-0253-7
- By:
- Publication type:
- Article
Early Add-on Lacosamide in a Real-Life Setting: Results of the REALLY Study.
- Published in:
- Clinical Drug Investigation, 2015, v. 35, n. 2, p. 121, doi. 10.1007/s40261-014-0255-5
- By:
- Publication type:
- Article
An Investigation of Factors Contributing to Higher Levels of Placebo Response in Clinical Trials in Neuropathic Pain: A Systematic Review and Meta-Analysis.
- Published in:
- Clinical Drug Investigation, 2015, v. 35, n. 2, p. 67, doi. 10.1007/s40261-014-0259-1
- By:
- Publication type:
- Article
Additive Effects of Miglitol and Anagliptin on Insulin-Treated Type 2 Diabetes Mellitus: A Case Study.
- Published in:
- Clinical Drug Investigation, 2015, v. 35, n. 2, p. 141, doi. 10.1007/s40261-014-0260-8
- By:
- Publication type:
- Article
Single-Dose, Open-Label Study of the Differences in Pharmacokinetics of Colchicine in Subjects with Renal Impairment, Including End-Stage Renal Disease.
- Published in:
- Clinical Drug Investigation, 2015, v. 35, n. 2, p. 149, doi. 10.1007/s40261-014-0262-6
- By:
- Publication type:
- Article
Interpreting the Results of a Retrospective Comparison of Test and Reference Treatments in a Randomized Clinical Trial Setting.
- Published in:
- Clinical Drug Investigation, 2015, v. 35, n. 2, p. 133, doi. 10.1007/s40261-014-0263-5
- By:
- Publication type:
- Article
Cost Effectiveness of Mirabegron Compared with Tolterodine Extended Release for the Treatment of Adults with Overactive Bladder in the United Kingdom.
- Published in:
- Clinical Drug Investigation, 2015, v. 35, n. 2, p. 83, doi. 10.1007/s40261-014-0240-z
- By:
- Publication type:
- Article